Answers are grounded in this paper and cite their sources.
Introduction Deep brain stimulation (DBS) is a therapeutic option for treatment-resistant obsessive–compulsive disorder (OCD). Relative efficacy of regions that are currently being targeted for the treatment of OCD has not previously been investigated. We conducted a systematic review and meta-analysis to assess and compare the efficacy of DBS treatment across conventional targets for OCD. Methods We performed a search of clinical studies investigating the efficacy of DBS for OCD. Relevant articles were retrieved from OVID, PubMed and Web of Science from database inception to 26 January 2026. For all studies, response rate to DBS treatment by region and changes in Yale-Brown Obsessive–Compulsive Scale (Y-BOCS) score over time were assessed. Results In total, 33 studies were included in the systematic review. Of which data of 447 unique patients across 30 studies were used to assess response rates by regions. Changes in Y-BOCS score were assessed using data from 363 patients from 27 studies. No significant difference in response rate was observed across targets. Of all stimulation targets, the ventral capsule/ventral striatum demonstrated highest pooled efficacy (SMCR=−7.92 (SMCR, standardised mean change using raw score standardisation); 95% CI (−12.16 to −3.68)). Conclusion Clinical studies underscore the efficacy of DBS for OCD, highlighting the effectiveness of stimulating the cortico-striato-thalamo-cortical circuit and the bed nucleus of the stria terminalis separately. Assessing the efficacy of all DBS targets better informs target selection for the treatment of OCD.
No takes yet. Share an insight, caveat, or question.
Au et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: